Based on the above, we can say that there is an alteration in gene expression that results in an elevated regulation of GFAP and inflammatory mediators, in addition to adipokine receptors, due to overweight/obesity [34,36]. The gene discussed is GFAP; the disease is obesity due to melanocortin 4 receptor deficiency.